• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Bluebird Bio submits BLA for sickle cell disease gene therapy

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 24, 2023 at 11:42: AM
via bluebird bio has today announced the submission of a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for lovotibeglogene autotemcel (lovo-cel) gene therapy in patients with sickle cell disease (SCD).

article source
 

<



Similar threads

cafead
Bluebird bio inks first Medicaid coverage agreement for sickle cell gene therapy, signing...
Replies
0
Views
138
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Why Bluebird Bio Stock Dived Into the Red on Tuesday
Replies
0
Views
60
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Bluebird bio&#039;s Lyfgenia launch progresses with 2nd major outcomes-based coverage deal
Replies
0
Views
224
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Bluebird bio to sell sickle cell FDA voucher for $103 mln if therapy approved
Replies
0
Views
174
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Lifts Partial Clinical Hold On Bluebird Bio&#039;s Sickle Cell Disease Studies
Replies
0
Views
126
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote